Good morning :)
Laxmi Dental Ltd

Laxmi Dental Ltd

LAXMIDENTL Share Price

NSE
223.740.32% (+0.71)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹1,229 cr, stock is ranked 1,442

Stock is 4.17x as volatile as Nifty

LAXMIDENTL Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹1,229 cr, stock is ranked 1,442

Stock is 4.17x as volatile as Nifty

LAXMIDENTL Performance & Key Metrics

LAXMIDENTL Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
42.455.89
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
41.316.170.56%

LAXMIDENTL Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 3 analysts

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

LAXMIDENTL Company Profile

Laxmi Dental Ltd manufactures and supplies a comprehensive range of dental products including prosthetics, aligners, and dental consumables, catering to dental laboratories and clinics.

Investor Presentation

View older View older 

Feb 10, 2026

PDF
View Older Presentations

LAXMIDENTL Similar Stocks (Peers)

Compare with peers Compare with peers 

LAXMIDENTL Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
38.92
38.92
1Y Return
3.42%
3.42%
Buy Reco %
87.50
87.50
PE Ratio
49.19
49.19
1Y Return
23.82%
23.82%
Buy Reco %
75.00
75.00
PE Ratio
97.58
97.58
1Y Return
28.95%
28.95%
Buy Reco %
100.00
100.00
PE Ratio
39.76
39.76
1Y Return
13.32%
13.32%
Buy Reco %
0.00
0.00
PE Ratio
18.73
18.73
1Y Return
177.48%
177.48%
Buy Reco %
0.00
0.00
Compare with Peers

LAXMIDENTL Sentiment Analysis

LAXMIDENTL Sentiment Analysis

New
Crisp summary & key insights to decode earnings calls instantly

LAXMIDENTL Stock Summary · February 2026

Laxmi Dental Limited demonstrated resilience in Q3 FY26, reporting a revenue increase of 7.1% year-on-year despite external challenges such as US tariffs and competitive pressures. The recent reduction in tariffs is expected to enhance profitability and customer engagement, particularly in the U.S. market, while strategic initiatives in digital dentistry aim to drive growth and operational efficiency. Although the domestic lab business faced softness, management remains optimistic about a strong recovery in Q4, bolstered by innovative product launches and a focus on international expansion. The company is committed to overcoming regulatory hurdles and enhancing digital penetration, recognizing the significant potential for growth in the evolving dental landscape.

LAXMIDENTL Stock Growth Drivers
LAXMIDENTL Stock Growth Drivers
7
  • Revenue Growth and Financial Performance

    Laxmi Dental Limited reported a revenue of INR 66 crores in Q3 FY26, marking a

  • International Market Expansion

    The company has experienced significant growth in its international business, particularly in the US market,

LAXMIDENTL Stock Challenges
LAXMIDENTL Stock Challenges
5
  • Decline in Sales and Revenue

    The company experienced a significant decline in sales during the current quarter, which was unexpected

  • Margin Compression

    Laxmi Dental Limited reported a significant decline in EBITDA margins, with a quarter-on-quarter drop of

LAXMIDENTL Forecast

LAXMIDENTL Forecasts

Price

Revenue

Earnings

LAXMIDENTL

LAXMIDENTL

Income

Balance Sheet

Cash Flow

LAXMIDENTL Income Statement

LAXMIDENTL Income Statement

Loading...

Quarterdec 2023mar 2024jun 2024sep 2024dec 2024mar 2025jun 2025sep 2025dec 2025mar 2026
Total Revenue47.9955.3666.6757.8562.2562.7167.3274.6568.1276.31
Operating & Other expensessubtract44.4244.0946.3648.3952.0551.1453.6961.2464.8560.45
Depreciation/Amortizationsubtract3.253.263.373.403.954.303.583.754.174.38
Interest & Other Itemssubtract1.331.401.421.181.541.260.460.240.320.35
Taxes & Other Itemssubtract-3.29-0.91-1.28-1.01-0.091.731.210.88-3.201.06
EPS76.30247.013.242.120.880.791.531.590.371.83

LAXMIDENTL Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2026FY 2026

Annual Report Pending

Investor Presentation

Feb 10PDF
Nov 11PDF
Aug 12PDF
FY 2025FY 2025

Annual report

PDF

Investor Presentation

May 27PDF
Feb 14PDF
Feb 13PDF
 

LAXMIDENTL Stock Peers

LAXMIDENTL Past Performance & Peer Comparison

LAXMIDENTL Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CareHealth Care Equipment & Supplies

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Laxmi Dental Ltd42.455.89
Inventurus Knowledge Solutions Ltd38.9215.69
Poly Medicure Ltd49.195.730.22%
Tarsons Products Ltd97.582.22

LAXMIDENTL Stock Price Comparison

Compare LAXMIDENTL with any stock or ETF
Compare LAXMIDENTL with any stock or ETF
LAXMIDENTL
Loading...

LAXMIDENTL Holdings

LAXMIDENTL Shareholdings

LAXMIDENTL Promoter Holdings Trend

LAXMIDENTL Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

LAXMIDENTL Institutional Holdings Trend

LAXMIDENTL Institutional Holdings Trend

Increased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has increased by 1.34%

Decreased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has decreased by 1.25%

Tickertape Separator

LAXMIDENTL Shareholding Pattern

LAXMIDENTL Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding41.77%10.32%0.20%31.21%16.50%

Jun 2025

Sep 2025

Dec 2025

Mar 2026

LAXMIDENTL Shareholding History

LAXMIDENTL Shareholding History

JanMarJunSepDec '25Mar29.49%34.24%33.59%32.39%32.45%31.21%

Mutual Funds Invested in LAXMIDENTL

Mutual Funds Invested in LAXMIDENTL

No mutual funds holding trends are available

Top 5 Mutual Funds holding Laxmi Dental Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
4.1885%0.80%0.17%33/48 (+1)
1.2226%0.63%0.02%33/37 (-6)
1.1357%1.14%0.88%35/45 (+9)

Compare 3-month MF holding change on Screener

LAXMIDENTL Insider Trades & Bulk Stock Deals

LAXMIDENTL Insider Trades & Bulk Stock Deals

Loading...

smallcases containing LAXMIDENTL stock

smallcases containing LAXMIDENTL stock

Looks like this stock is not in any smallcase yet.

LAXMIDENTL Events

LAXMIDENTL Events

LAXMIDENTL Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

LAXMIDENTL has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

LAXMIDENTL Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

LAXMIDENTL has not given any dividends in last 5 years

LAXMIDENTL Dividends

LAXMIDENTL Dividends

Hmm, looks like data is unavailable here. Please come back after some time

LAXMIDENTL Stock News & Opinions

LAXMIDENTL Stock News & Opinions

Spotlight
Spotlight
Laxmi Dental soars after Q4 FY26 profit jumps 136% YoY

The company's consolidated profit after tax after share of profit/loss from joint ventures surged 136.1% YoY to Rs 10.09 crore in Q4 FY26 from Rs 4.27 crore in Q4 FY25. Sequentially, PAT jumped 414.6% from Rs 1.96 crore reported in Q3 FY26. Revenue from operations rose 21.9% YoY and 12% QoQ to Rs 73.95 crore during the quarter. The company said Q4 FY26 marked its highest-ever quarterly revenue. EBITDA climbed 41.8% YoY and 93.8% sequentially to Rs 13.5 crore in Q4 FY26. EBITDA margin improved to 18.3% from 15.7% in the year-ago quarter and 10.5% in Q3 FY26. The company said EBITDA during the quarter was impacted by around 74 basis points due to higher US tariffs during the first half of the quarter. Gross profit margins stood at 70.5% during the quarter, showing sequential improvement despite a higher contribution from lower-margin scanner sales. The company said gross margins for the core dental business excluding scanner sales remained steady at around 76%. Profit before tax and exceptional items jumped 98.8% YoY to Rs 11.14 crore in Q4 FY26, while reported profit before tax rose 85.3% to Rs 11.14 crore from Rs 6.01 crore in Q4 FY25. On the cost front, raw material cost surged 187.35% YoY to Rs 11.81 crore in Q4 FY26. Employee benefit expenses rose 9.6% YoY to Rs 26.76 crore in Q4 FY26. Finance costs declined sharply by 72.2% to Rs 0.35 crore from Rs 1.26 crore, while depreciation and amortisation expenses increased marginally by 2.1% to Rs 4.38 crore from Rs 4.29 crore. Other expenses declined 14.2% YoY to Rs 11.87 crore from Rs 13.84 crore. For FY26, consolidated revenue from operations increased 16.2% YoY to Rs 277.86 crore from Rs 239.11 crore in FY25. EBITDA rose 3.6% to Rs 43.4 crore, while EBITDA margin stood at 15.6% compared with 17.5% in FY25. FY26 profit before tax and exceptional items rose 39.9% YoY to Rs 34.7 crore. However, reported profit before tax declined 9.1% to Rs 28.93 crore, while PAT after share of profit/loss from joint ventures fell 9.2% to Rs 28.92 crore. Management said FY26 margins were impacted by multiple one-off factors, including a 72 basis points impact from US tariffs, a one-time expense of Rs 5.78 crore related to labour code changes, and higher ESOP expenses of Rs 5.26 crore compared with Rs 2.19 crore in FY25. FY25 also included an exceptional gain of Rs 7.03 crore from property sale, making the base non-comparable. The company recorded a tax benefit of Rs 1.3 crore in Q4 FY26 related to the one-time gratuity provision recognised in Q3 FY26 following labour code changes. Net cash flow used in operating activities stood at Rs 4.99 crore in FY26 compared with net cash generated from operating activities of Rs 43.83 crore in FY25, mainly due to higher working capital deployment. Commenting on the performance, Rajesh Khakhar, chairperson and whole-time director of Laxmi Dental, said the company delivered its strongest-ever quarterly performance despite geopolitical uncertainties and higher US tariffs. He added that digital penetration in the Indian dental business stood at around 80%. Managing director and CEO Sameer Merchant said the dental laboratory business reported its highest-ever quarterly performance with 27% YoY growth, supported by recovery in domestic operations and record international revenue. The aligner solutions business reported revenue of Rs 18 crore during the quarter, while Bizdent, the clear aligner business, recorded 11% YoY growth. Laxmi Dental is an integrated dental products company engaged in manufacturing custom-made crowns and bridges, clear aligners, thermoforming sheets and other dental products with operations across India and exports to over 95 countries. Powered by Capital Market - Live

4 weeks agoCapital Market - Live
Earnings
Earnings
Laxmi Dental consolidated net profit rises 135.51% in the March 2026 quarter

Net profit of Laxmi Dental rose 135.51% to Rs 10.08 crore in the quarter ended March 2026 as against Rs 4.28 crore during the previous quarter ended March 2025. Sales rose 19.46% to Rs 72.18 crore in the quarter ended March 2026 as against Rs 60.42 crore during the previous quarter ended March 2025. For the full year,net profit declined 8.78% to Rs 28.98 crore in the year ended March 2026 as against Rs 31.77 crore during the previous year ended March 2025. Sales rose 14.77% to Rs 271.50 crore in the year ended March 2026 as against Rs 236.56 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales72.1860.42 19 271.50236.56 15 OPM %18.7015.77 -15.9917.70 - PBDT15.529.90 57 50.5839.82 27 PBT11.145.60 99 34.7124.80 40 NP10.084.28 136 28.9831.77 -9 Powered by Capital Market - Live

4 weeks agoCapital Market - Live
Corporate
Corporate
Laxmi Dental to convene board meeting

Laxmi Dental will hold a meeting of the Board of Directors of the Company on 21 May 2026.

1 month agoCapital Market - Live
Spotlight
Spotlight
Laxmi Dental tanks as Q3 PAT drops 59% YoY to Rs 2 cr

However, total income jumped 9.43% to Rs 68.11 crore in Q3 FY26 as against Rs 62.24 crore in Q3 FY25. The company posted pre loss tax of Rs 1.28 crore in Q3 FY26 as against profit before tax of Rs 4.71 crore in Q3 FY25. EBITDA fell by 27.47% to Rs 6.97 crore in Q3 FY26, compared with Rs 9.61 crore recorded in the similar quarter last year. EBITDA Margin redcuced to 10.6% in Q3 FY26 as against 15.6% in Q3 FY25. Based on the requirements of the new labour codes, the company recorded an incremental impact of Rs 5.8 crore as an exceptional item for the quarter. Rajesh Khakhar, Chairperson and whole-time director (WTD) said, 'In Q3FY26, the company delivered revenues of Rs 660 Mn as against Rs 61.7 cr in same period last year, recording a YoY growth of 7%. The performance is despite global macroeconomic and geopolitical challenges, underscoring the strength and resilience of our diversified portfolio. Gross profit margins witnessed minor improvement sequentially due to steady profitability in the laboratory and aligner business alongside a relatively lower contribution of scanner sales, which are low margin in nature. Scanner sales hold strategic importance for future growth across segments. During Q3, we had a full quarter impact of 150 bps on account of higher US tariffs. Additionally, we recorded a one-time exceptional provision of Rs 58 Mn towards gratuity past service liability under the new labour code. With US tariff normalization, positive development of EU FTA, multiple ongoing strategic initiatives, and consolidation in the domestic dental market, Laxmi Dental is well positioned to deliver resilient, industry-leading growth along with improved profitability going ahead.' Sameer Merchant, Managing Director and CEO, said, 'For Q3FY26, our Dental Lab business recorded a healthy YoY growth of 10.4%, with the international business delivering robust 25.5% YoY growth, while the domestic lab remained soft. During the quarter, we implemented innovative strategies, which have started showing positive results in January 2026. Within the Aligner Solutions business, competitive pricing pressures on Bizdent are normalizing in Q4FY26, and we anticipate the situation to remain favorable throughout the quarter. With these new strategic initiatives, we are witnessing a strong recovery in our domestic Dental Lab and Bizdent businesses, and we expect both segments to deliver robust YoY performance in Q4FY26. On the back of these positive trends, we aim to close FY26 with a healthy exit quarter and begin FY27 on a stronger footing. Over the long term, we remain committed to promoting digital dentistry and leading this transformation across the Indian dental industry, leveraging our scanner solutions.' Laxmi Dental is an integrated dental products company offering a comprehensive portfolio of Dental Products. Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Earnings
Laxmi Dental consolidated net profit declines 58.75% in the December 2025 quarter

Net profit of Laxmi Dental declined 58.75% to Rs 1.98 crore in the quarter ended December 2025 as against Rs 4.80 crore during the previous quarter ended December 2024. Sales rose 5.87% to Rs 64.02 crore in the quarter ended December 2025 as against Rs 60.47 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales64.0260.47 6 OPM %10.8715.89 - PBDT8.728.67 1 PBT4.554.71 -3 NP1.984.80 -59 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Corporate
Laxmi Dental to table results

Laxmi Dental will hold a meeting of the Board of Directors of the Company on 10 February 2026.Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Earnings
Laxmi Dental consolidated net profit rises 44.82% in the September 2025 quarter

Net profit of Laxmi Dental rose 44.82% to Rs 8.53 crore in the quarter ended September 2025 as against Rs 5.89 crore during the previous quarter ended September 2024. Sales rose 25.47% to Rs 70.98 crore in the quarter ended September 2025 as against Rs 56.57 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales70.9856.57 25 OPM %15.5315.41 - PBDT13.178.28 59 PBT9.424.88 93 NP8.535.89 45 Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Corporate
Laxmi Dental to table results

Laxmi Dental will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Corporate
Laxmi Dental to hold AGM

Laxmi Dental announced that the Annual General Meeting(AGM) of the company will be held on 29 September 2025.Powered by Capital Market - Live

9 months agoCapital Market - Live
Corporate
Corporate
Laxmi Dental schedules board meeting

Laxmi Dental will hold a meeting of the Board of Directors of the Company on 12 August 2025.Powered by Capital Market - Live

10 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Laxmi Dental Ltd (LAXMIDENTL) today?

    The share price of LAXMIDENTL as on 19th June 2026 is ₹223.74. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Laxmi Dental Ltd (LAXMIDENTL) share?

    The past returns of Laxmi Dental Ltd (LAXMIDENTL) share are
    • Past 1 week: 4.07%
    • Past 1 month: 13.00%
    • Past 3 months: 26.27%
    • Past 6 months: -14.47%
    • Past 1 year: -43.25%
    • Past 3 years: N/A%
    • Past 5 years: -59.36%

  3. What are the peers or stocks similar to Laxmi Dental Ltd (LAXMIDENTL)?
  4. What is the market cap of Laxmi Dental Ltd (LAXMIDENTL) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Laxmi Dental Ltd (LAXMIDENTL) is ₹1229.72 Cr as of 19th June 2026.

  5. What is the 52 week high and low of Laxmi Dental Ltd (LAXMIDENTL) share?

    The 52-week high of Laxmi Dental Ltd (LAXMIDENTL) is ₹509.95 and the 52-week low is ₹155.88.

  6. What is the PE and PB ratio of Laxmi Dental Ltd (LAXMIDENTL) stock?

    The P/E (price-to-earnings) ratio of Laxmi Dental Ltd (LAXMIDENTL) is 42.45. The P/B (price-to-book) ratio is 5.89.

  7. Which sector does Laxmi Dental Ltd (LAXMIDENTL) belong to?

    Laxmi Dental Ltd (LAXMIDENTL) belongs to the Health Care sector & Health Care Equipment & Supplies sub-sector.

  8. How to buy Laxmi Dental Ltd (LAXMIDENTL) shares?

    You can directly buy Laxmi Dental Ltd (LAXMIDENTL) shares on Tickertape. Simply sign up, connect your demat account and place your order.